CSF proteomics and machine learning reveal distinct stages across the Alzheimer’s disease continuum
These findings uncover protein signatures that reflect underlying AD biology and provide a foundation for stage-specific biomarkers and therapeutic targeting, with important implications for patient stratification and personalized intervention strategies.